Dasatinib - Xspray Pharma
Alternative Names: Dasynoc; HyNap-Dasa; XS-004Latest Information Update: 19 Aug 2025
At a glance
- Originator Xspray Pharma
- Class Alcohols; Amides; Amines; Antineoplastics; Chlorobenzenes; Ethanolamines; Piperazines; Pyrimidines; Small molecules; Thiadiazoles; Thiazoles
- Mechanism of Action Bcr-Abl fusion protein modulators; Bcr-Abl tyrosine kinase inhibitors; EphA2 receptor antagonists; Platelet-derived growth factor beta receptor antagonists; Proto-oncogene protein c-kit inhibitors; Src-family kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma